aurintricarboxylic acid has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, H; Wei, W; Xie, X; Zhang, F | 1 |
1 other study(ies) available for aurintricarboxylic acid and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
Aurintricarboxylic acid ameliorates experimental autoimmune encephalomyelitis by blocking chemokine-mediated pathogenic cell migration and infiltration.
Topics: Adoptive Transfer; Amino Acid Sequence; Animals; Apoptosis; Aurintricarboxylic Acid; CD4-Positive T-Lymphocytes; Cells, Cultured; Central Nervous System; Chemotaxis, Leukocyte; Dendritic Cells; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Lymphopoiesis; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Sequence Data; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Receptors, Chemokine; Spleen; Th17 Cells | 2013 |